Medical
CAR T-Cell Therapy for Mesothelioma: NCI's $10.7 Million Research Initiative Targets 63.6% Response Rate
David Foster
February 19, 2026
NCI awards $10.7M to Penn for CAR T-cell therapy targeting mesothelin in mesothelioma. Explore clinical data, eligibility, and breakthrough cell immunotherapy.
13 min read 8 FAQs
Read